Antioxidant Synergy in Skincare: Does Combining Two Actives Always Improve Performance?
A laboratory report shows that antioxidant A achieves 40% radical-scavenging activity under a particular test condition. Antioxidant B reaches 30%.
The formulator combines them. The mixture produces 58%.
Is that evidence of synergy?
The answer depends on what those percentages represent, the concentrations used and the model chosen to predict the combined effect.
Without that information, 58% is simply another experimental result.
Why 40% + 30% Isn’t a Reliable Calculation
Antioxidant activity is often reported as a percentage of inhibition or radical scavenging. These values can be useful within a defined assay, but they are not interchangeable with ingredient concentrations.
Suppose two compounds are tested separately and then together. If the combined sample gives a higher inhibition percentage, the improvement could arise from their independent contributions.
It might also reflect an interaction between the compounds. Or it could result from changes in solubility, reaction kinetics or interference with the analytical method.
Simply adding the two percentages is not a valid universal method for deciding whether synergy has occurred.
The expected combined response must be calculated using a model appropriate to the experiment. Depending on the mechanism and endpoint, researchers may use approaches based on independent action, concentration addition or other established interaction models.
The experimental design must also account for the total dose. Comparing a mixture containing twice as much total antioxidant with either ingredient alone can exaggerate the apparent benefit of combining them.
An Antioxidant Assay Measures a Particular Reaction
DPPH and ABTS assays are widely used because they are relatively convenient ways to investigate the chemical antioxidant behavior of ingredients.
They are useful for screening, but the results depend on the reaction environment.
The solvent can influence how well a compound dissolves and reacts. The measurement time matters because antioxidants do not necessarily react at the same rate. Sample color or other constituents may interfere with spectrophotometric readings.
There is also a more fundamental limitation.
DPPH and ABTS use laboratory-generated radical probes rather than the complete oxidative processes occurring in human skin.
Schaich et al. (2015) examined these limitations, particularly the effects of reaction kinetics, solvent conditions and the chemical nature of the test radicals.
This doesn’t make the assays useless. It means that their conclusions need to remain within the scope of what was measured.
A stronger DPPH result does not, by itself, demonstrate greater protection against oxidative stress in skin.
What Changes When Antioxidants Enter a Cosmetic Formula?
Consider a formula containing a lipophilic botanical active alongside tocopherols.
The individual ingredients may have demonstrated antioxidant-related activity in laboratory research. Yet their behavior in an emulsion can differ from their behavior in a homogeneous test solution.
Get Skye’s stories in your inbox
Join Medium for free to get updates from this writer.
Their distribution between oil and water phases, local concentrations and exposure to oxygen can influence the outcome.
An antioxidant may help protect a formulation’s lipid phase from oxidation without necessarily providing a measurable antioxidant benefit to the skin.
Those are different development objectives.
The same distinction applies when considering Glabridin, mixed tocopherols or Totarol. Their antioxidant-related properties provide a scientific reason to investigate combinations, but they do not establish synergy in any specific formula.
A formulator needs to define the desired outcome before choosing the experiment.
Is the goal to protect the formula against oxidation during storage?
Or to demonstrate a biological effect associated with oxidative stress?
The appropriate methods and evidence will differ.
How Would a Formulator Test the Combination?
A useful experimental plan would begin with concentration-response data for each ingredient separately.
The mixture should then be tested at several concentrations and ratios, rather than at one arbitrarily selected combination.
Solvent controls, appropriate blanks and analytical interference checks are important, particularly when testing colored botanical extracts.
The observed mixture response can then be compared with a justified additive-effect model. Replicate measurements and statistical analysis are needed to establish whether any apparent deviation is meaningful.
If the intended benefit concerns skin biology, chemical screening should be followed by suitable biological models and, where needed for the proposed claim, finished-product human studies.
A positive result at one experimental level does not automatically validate every subsequent claim.
FAQ
Does a higher antioxidant inhibition percentage prove synergy?
No. Synergy requires evidence that the observed combination effect exceeds an appropriate expected effect, with concentration and experimental conditions properly controlled.
Can DPPH or ABTS results predict clinical skincare benefits?
Not on their own. These assays measure chemical reactions under defined laboratory conditions. They do not directly establish clinical efficacy.
Can antioxidants work together without being synergistic?
Yes. A combination may have useful additive effects or provide different functions in a formula without demonstrating synergy.
Can mixed tocopherols be combined with botanical antioxidants?
They can be considered as candidates for formulation research, subject to compatibility, stability and safety evaluation. The performance of a particular combination must be tested rather than assumed.
References
Schaich, K. M., Tian, X., & Xie, J. (2015). Hurdles and pitfalls in measuring antioxidant efficacy: A critical evaluation of ABTS, DPPH, and ORAC assays. Journal of Functional Foods, 14, 111–125. DOI: 10.1016/j.jff.2015.01.043.
